Ameliora Wealth Management Ltd. Has $2.60 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Ameliora Wealth Management Ltd. increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% during the first quarter, Holdings Channel reports. The fund owned 4,964 shares of the healthcare conglomerate’s stock after acquiring an additional 45 shares during the quarter. UnitedHealth Group makes up 1.0% of Ameliora Wealth Management Ltd.’s holdings, making the stock its 26th largest holding. Ameliora Wealth Management Ltd.’s holdings in UnitedHealth Group were worth $2,600,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently added to or reduced their stakes in UNH. NewSquare Capital LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in UnitedHealth Group during the fourth quarter valued at $26,000. Hurley Capital LLC acquired a new position in UnitedHealth Group in the 4th quarter worth about $28,000. Aster Capital Management DIFC Ltd acquired a new position in UnitedHealth Group in the 4th quarter worth about $30,000. Finally, Promus Capital LLC acquired a new position in UnitedHealth Group in the fourth quarter worth approximately $32,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 0.0%

NYSE:UNH opened at $303.08 on Tuesday. The company has a market cap of $274.94 billion, a PE ratio of 19.55, a P/E/G ratio of 1.37 and a beta of 0.44. The firm’s 50 day simple moving average is $404.62 and its 200 day simple moving average is $480.59. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the previous year, the firm posted $6.91 earnings per share. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be paid a $2.21 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.92%. The ex-dividend date of this dividend is Monday, June 16th. UnitedHealth Group’s dividend payout ratio is currently 37.02%.

Insider Activity

In other news, CEO Stephen J. Hemsley bought 86,700 shares of the company’s stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now directly owns 679,493 shares in the company, valued at approximately $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CFO John F. Rex bought 17,175 shares of the business’s stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the transaction, the chief financial officer now owns 203,796 shares in the company, valued at $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have bought 109,408 shares of company stock valued at $31,607,768. 0.33% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. Barclays lowered their price objective on UnitedHealth Group to $350.00 and set an “overweight” rating on the stock in a report on Monday, June 2nd. Erste Group Bank downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. Royal Bank of Canada lowered their target price on shares of UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating on the stock in a research note on Friday, May 16th. TD Cowen downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price target on the stock. in a research report on Monday, May 19th. Finally, Oppenheimer lowered their target price on UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating on the stock in a report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have given a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $428.43.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.